Review: The choice and cardiovascular safety of particular nonsteroidal anti-inflammatory drugs Cover

.blurhash-client-img { display: none !important; }

Review: The choice and cardiovascular safety of particular nonsteroidal anti-inflammatory drugs

Seminars in Cardiovascular Medicine

Volume 24 (2018): Issue 1 (August 2018)

By: Jonas Černeckis, Austėja Samuolytė, Greta Baltušytė, Rugilė Ivanickaitė and Kristijonas Puteikis

Open Access

|Sep 2018

Authors

Jonas Černeckis

jc2072@cam.ac.uk

University of Cambridge, Homerton College Cambridge,, Cambridge, UK

Austėja Samuolytė

Vilnius Lyceum,, Vilnius, Lithuania

Greta Baltušytė

Vilnius Lyceum,, Vilnius, Lithuania

Rugilė Ivanickaitė

Vilnius University, Faculty of Chemistry and Geosciences,, Vilnius, Lithuania

Kristijonas Puteikis

Vilnius University, Faculty of Medicine,, Vilnius, Lithuania

DOI: https://doi.org/10.2478/semcard-2018-0003 | Journal eISSN: 1822-7767

Journal RSS Feed

Language: English

Page range: 16 - 21

Submitted on: Sep 5, 2017

|

Accepted on: Feb 14, 2018

|

Published on: Sep 1, 2018

Published by: Sciendo

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

cardiovascular risk,

diclofenac safety,

NSAID guidelines

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

© 2018 Jonas Černeckis, Austėja Samuolytė, Greta Baltušytė, Rugilė Ivanickaitė, Kristijonas Puteikis, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 24 (2018): Issue 1 (August 2018)Next article